GENE ONLINE|News &
Opinion
Blog

2025-01-28|

Easing the Mental Health Burden: How MDMA, Psilocybin, and Other Psychedelics May Open Doors for Treating PTSD, Addiction, and Autism

by Bernice Lottering
Share To
As clinical trials progress and regulatory frameworks evolve, new therapies are emerging for complex, co-occurring conditions. Where will the field of psychedelic therapies for PTSD, addiction, and mental health disorders go next in advancing treatment? Image: Getty Images
As the global mental health crisis intensifies, innovative solutions are gaining traction in the form of psychedelic therapies. Once viewed with skepticism, substances like MDMA, …

Easing the Mental Health Burden: How MDMA, Psilocybin, and Other Psychedelics May Open Doors for Treating PTSD, Addiction, and Autism Read More »

GO Prime with only $1.49 now

LATEST
Sprout Social Integrates Lumanu Payment Processing for Influencer Campaigns
2026-06-18
Hilton Partners With Big Brothers Big Sisters to Provide Hospitality Career Training for Youth
2026-06-18
Pacific Life Launches Income Horizon Collective Investment Trust Series for Retirement Plans
2026-06-18
Synovis Micro Companies Alliance to Distribute MediThinQ SHIYA 3D Visualization Platform Globally
2026-06-18
Diamond Estates Wines & Spirits Inc. Renews Investor Relations Agreement with Atrium Research
2026-06-18
Social Media Replaces Traditional Channels as Primary Tool for Corporate Crisis Management
2026-06-18
Life360 and Uber Partner to Allow Parents to Book and Track Rides Within the Life360 App
2026-06-18
Scroll to Top